These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11173326)

  • 21. Observational comparative trial of the efficacy of proton pump inhibitors versus histamine-2 receptor antagonists for uninvestigated dyspepsia.
    Nagahara A; Asaoka D; Hojo M; Oguro M; Shimada Y; Ishikawa D; Osada T; Kawabe M; Yoshizawa T; Otaka M; Watanabe S
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S122-8. PubMed ID: 20586853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Gastroesophageal reflux disease and dyspepsia--drug therapy].
    Gräter H
    Praxis (Bern 1994); 2006 Aug; 95(31-32):1179-83. PubMed ID: 16909686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel concepts in the pathophysiology and treatment of functional dyspepsia.
    Wauters L; Talley NJ; Walker MM; Tack J; Vanuytsel T
    Gut; 2020 Mar; 69(3):591-600. PubMed ID: 31784469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Functional dyspepsia: the past, the present and the Rome III classification].
    Buzás GM
    Orv Hetil; 2007 Aug; 148(33):1573-9. PubMed ID: 17686677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of sleep disorders in Japanese patients with functional dyspepsia (FD): nizatidine improves clinical symptoms, gastric emptying and sleep disorders in FD patients.
    Futagami S; Yamawaki H; Izumi N; Shimpuku M; Kodaka Y; Wakabayashi T; Nagoya H; Shindo T; Kawagoe T; Gudis K; Itoh T; Sakamoto C
    J Gastroenterol Hepatol; 2013 Aug; 28(8):1314-20. PubMed ID: 23611167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological interventions for non-ulcer dyspepsia.
    Moayyedi P; Soo S; Deeks J; Delaney B; Innes M; Forman D
    Cochrane Database Syst Rev; 2003; (1):CD001960. PubMed ID: 12535421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pretreatment prediction of symptom response to proton pump inhibitor therapy.
    Nagahara A; Miwa H; Asaoka D; Shimada Y; Sasaki H; Matsumoto K; Osada T; Hojo M; Watanabe S
    J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():25-30. PubMed ID: 25827800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomised clinical trial: sustained response to PPI treatment of symptoms resembling functional dyspepsia and irritable bowel syndrome in patients suffering from an overlap with erosive gastro-oesophageal reflux disease.
    Mönnikes H; Schwan T; van Rensburg C; Straszak A; Theek C; Sander P; Lühmann R
    Aliment Pharmacol Ther; 2012 Jun; 35(11):1279-89. PubMed ID: 22486552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton pump inhibitors for dyspepsia.
    Vakil N
    Dig Dis; 2008; 26(3):215-7. PubMed ID: 18463438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Randomized, Double-Blind, Pilot Study of the Effect of Famotidine on Acotiamide Treatment for Functional Dyspepsia.
    Hojo M; Nagahara A; Asaoka D; Takeda T; Izumi K; Matsumoto K; Ueyama H; Shimada Y; Matsumoto K; Nojiri S; Watanabe S
    Digestion; 2017; 96(1):5-12. PubMed ID: 28605740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Endoscopy for treatment with H2 blockaders?].
    Schmidt VM
    Ugeskr Laeger; 1995 May; 157(18):2588-90. PubMed ID: 7778246
    [No Abstract]   [Full Text] [Related]  

  • 32. Demography and treatment response in patients with predominant non-erosive reflux disease or functional dyspepsia.
    Miwa H; Haruma K; Sakamoto S; Sanada K; Hiroi S; Kinoshita Y
    J Gastroenterol Hepatol; 2015 May; 30(5):834-41. PubMed ID: 25559435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Symptomatic treatment and H. pylori eradication therapy for nonulcer dyspepsia.
    Smucny J
    Am Fam Physician; 2001 Nov; 64(9):1605-8. PubMed ID: 11730316
    [No Abstract]   [Full Text] [Related]  

  • 34. Are H2 blockers for symptom relief?
    Sampliner RE
    J Clin Gastroenterol; 1986 Feb; 8(1):8-9. PubMed ID: 2871068
    [No Abstract]   [Full Text] [Related]  

  • 35. [Role of acid in functional dyspepsia].
    Tomita T; Oshima T; Fukui H; Watari J; Miwa H
    Nihon Rinsho; 2015 Jul; 73(7):1202-8. PubMed ID: 26165081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dyspepsia and IBS symptoms in patients with NERD, ERD and Barrett's esophagus.
    Neumann H; Monkemuller K; Kandulski A; Malfertheiner P
    Dig Dis; 2008; 26(3):243-7. PubMed ID: 18463443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigating young patients with dyspepsia.
    Lancet; 1989 Jan; 1(8631):212. PubMed ID: 2563110
    [No Abstract]   [Full Text] [Related]  

  • 38. Development and validation of a simple and multifaceted instrument, GERD-TEST, for the clinical evaluation of gastroesophageal reflux and dyspeptic symptoms.
    Nakada K; Matsuhashi N; Iwakiri K; Oshio A; Joh T; Higuchi K; Haruma K
    World J Gastroenterol; 2017 Jul; 23(28):5216-5228. PubMed ID: 28811716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current indications for acid suppressants in dyspepsia.
    Bytzer P; Talley NJ
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):385-400. PubMed ID: 11403534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in patients' symptoms and gastric emptying after Helicobacter pylori treatment.
    Zhang CL; Geng CH; Yang ZW; Li YL; Tong LQ; Gao P; Gao YQ
    World J Gastroenterol; 2016 May; 22(18):4585-93. PubMed ID: 27182168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.